Figure 1.
Flow of samples, results, and MDR treatment requests and plans within the Peruvian National TB Program.
TB microscopy is carried out at point of care health centers, and smear positive samples are only referred for DST if there are risk factors for MDR TB.
Table 1.
Outcome definitions for turn-around-times (TAT) and their respective sample.
Figure 2.
Flow of participants, cultures and DSTs through trial.
The Pre-intervention groups represent baseline data collection prior to the RCT which was used to correct for baseline differences between sites during the analysis. Cx is sputum culture, DST is drug sensitivity test.
Table 2.
Characteristics, outcome measures, and sample sizes for all study health centers (HCs) and participants.
Table 3.
Primary and secondary outcomes.